[PAR] YoY Quarter Result on 30-Dec-2013 [#Q2]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
30-Dec-2013
Financial Year
2014
Quarter
30-Dec-2013 [#Q2]
Profit Trend
QoQ-
YoY-
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/01/15 30/12/13 CAGR
Revenue 826 28 22 58 46 0 0 -
PBT -5,104 -4,400 -3,573 -2,818 -1,423 -605 -116 87.78%
Tax 826 0 0 0 0 5 0 -
NP -5,104 -4,400 -3,573 -2,818 -1,423 -605 -116 87.78%
Tax Rate - - - - - - - -
Total Cost 5,930 4,428 3,595 2,876 1,469 605 116 92.53%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/01/15 30/12/13 CAGR
NP Margin -617.95 -15,636.11 -15,997.31 -4,891.09 -3,087.04 0.00 0.00 -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/01/15 30/12/13 CAGR
EPS -0.03 -0.03 -0.03 -0.03 -0.02 -0.04 -0.01 20.07%
EPS Diluted -0.03 -0.03 -0.03 -0.03 -0.02 -0.04 -0.01 20.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.